← All diseases
Heart and blood vessels
Cardiac amyloidosis
Would you like to receive a message when there is new research about cardiac amyloidosis? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, a single sentence appears above each publication explaining what was investigated — and you'll receive a notification as soon as new research on Cardiac Amyloidosis is available. View what Premium costs.
Publications (1060)
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Current role of imaging techniques in cardiac amyloidosis. (2023/02/10) ♡
- In-hospital mortality in amyloid light chain amyloidosis: analysis of the Premier Healthcare Database. (2023/02/01) ♡
- Characteristics of Patients with Hereditary Transthyretin Amyloidosis-Polyneuropathy (ATTRv-PN) in NEURO-TTRansform, an Open-label Phase 3 Study of Eplontersen. (2023/02/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. (99m)Tc Bone-Avid Tracer Cardiac Scintigraphy: Role in Noninvasive Diagnosis of Transthyretin Cardiac Amyloidosis. (2023/02/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Starting sacubitril-valsartan is safe in patients with transthyretin cardiac amyloidosis and impaired ejection fraction. (2023/02/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Implications of Extra-cardiac Disease in Patient Selection for Heart Transplantation: Considerations in Cardiac Amyloidosis. (2023/01/31) ♡
- Pro-inflammatory cytokine secretion induced by amyloid transthyretin in human cardiac fibroblasts. (2023/01/29) ♡
- Inotersen to Treat Polyneuropathy Associated with Hereditary Transthyretin (hATTR) Amyloidosis. (2023/01/28) ♡
- Evaluation of contemporary echocardiographic and histomorphology parameters in predicting mortality in patients with endomyocardial biopsy-proven cardiac AL amyloidosis. (2023/01/24) ♡
- Cardiac transplantation in transthyretin amyloid cardiomyopathy: Outcomes from three decades of tertiary center experience. (2023/01/19) ♡
- Prevalence of anxiety and depression symptoms in a sample of outpatients with ATTR cardiac amyloidosis. (2023/01/18) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Wild-Type Transthyretin Amyloid Cardiomyopathy: The Gordian-Knot of Novel Therapeutic Regimens. (2023/01/01) ♡
- Serial (99m)Technetium Pyrophosphate Scintigraphy and Multimodality Assessments After Different Doses of Tafamidis for Variant Transthyretin Cardiac Amyloidosis. (2023/01/01) ♡
- Clinical profile of patients with cardiac amyloidosis in India. (2023/01/01) ♡
- Wild type cardiac amyloidosis: is it time to order a nuclear technetium pyrophosphate SPECT imaging study? (2023/01/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Amyloid-β and the Risk of Heart Failure: Cause or Only Association? (2023/01/01) ♡
- Left ventricular myocardial work index and short-term prognosis in patients with light-chain cardiac amyloidosis: a retrospective cohort study. (2023/01/01) ♡
- Comparison of left ventricular global and segmental strain parameters by cardiovascular magnetic resonance tissue tracking in light-chain cardiac amyloidosis and hypertrophic cardiomyopathy. (2023/01/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Systemic immunoglobulin light chain (AL) amyloidosis initially presenting as hematochezia: a case report. (2023/01/01) ♡
- Lessons from Four Decades of Systemic Amyloidosis with Renal Involvement. (2023/01/01) ♡
- Cardiac and autologous stem cell transplantation hematopoietic in patients with AL amyloidosis. (2023/01/01) ♡
- CRISPR-Cas9 for the Treatment of Transthyretin Cardiac Amyloidosis. (2023/01/01) ♡
- Assessment of Interobserver Agreement in the Interpretation of (99m)Tc-PYP SPECT Imaging of Cardiac Amyloidosis. (2023/01/01) ♡
- Health care resource use, diagnostic delay and disease burden in transthyretin amyloid cardiomyopathy in Sweden. (2023/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The importance of pathways to facilitate early diagnosis and treatment of patients with cardiac amyloidosis. (2023/01/01) ♡
- Serial electrocardiographic and echocardiographic assessments of cardiac amyloidosis presenting with myocardial ischemia. (2023/01/01) ♡
- Registry of nuclear medicine procedures in cardiology in Poland in 2019-2021. (2023/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. A Comprehensive Review of Dilated Cardiomyopathy in Pre-clinical Animal Models in Addition to Herbal Treatment Options and Multi-modality Imaging Strategies. (2023/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The Role of Proteolysis in Amyloidosis. (2022/12/31) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [Cardiac progression of systemic light chain amyloidosis]. (2022/12/31) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Tafamidis Beyond the ATTR-ACT Trial: The Winner Takes It All. (2022/12/30) ♡
- Role of Diphosphonates Bone Scintigraphy in Correlation with Biomarkers for a Personalized Approach to ATTR Cardiac Amyloidosis in North-Eastern Romania. (2022/12/28) ♡
- CMR-based right ventricular strain analysis in cardiac amyloidosis and its potential as a supportive diagnostic feature. (2022/12/28) ♡
- Physical Performance in Black and Hispanic Outpatients With Heart Failure: The SCAN-MP Study. (2022/12/27) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Early and aggressive presentation of wild-type transthyretin amyloid cardiomyopathy: A case report. (2022/12/26) ♡
- Dual versus single energy cardiac CT to measure extra cellular volume in cardiac amyloidosis: Correlations with cardiac MRI. (2022/12/26) ♡
- The Apparent Organ-Specificity of Amyloidogenic ApoA-I Variants Is Linked to Tissue-Specific Extracellular Matrix Components. (2022/12/24) ♡
- [Clinical Practice Guidelines for diagnosis of organic involvement of amyloidosis: Part 3/3 Year 2020]. (2022/12/21) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Changing paradigm in the treatment of amyloidosis: From disease-modifying drugs to anti-fibril therapy. (2022/12/20) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Delayed Diagnosis and Recovery of Fulminant Immune Checkpoint Inhibitor-Associated Myocarditis on VA-ECMO Support. (2022/12/20) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Oral Therapy for the Treatment of Transthyretin-Related Amyloid Cardiomyopathy. (2022/12/18) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Amyloid deposition at the carotid artery in an ATTRwt amyloidosis patient: a case report. (2022/12/17) ♡
- A compartment-based myocardial density approach helps to solve the native T1 vs. ECV paradox in cardiac amyloidosis. (2022/12/16) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Diagnosis and management of AL amyloidosis due to B-cell non-Hodgkin lymphoma. (2022/12/15) ♡
- Improvements in Efficacy Measures With Tafamidis in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial. (2022/12/14) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Transthyretin Cardiac Amyloidosis: A Cardio-Orthopedic Disease. (2022/12/12) ♡
- Clinical challenges in the management of cardiac amyloidosis complicating aortic stenosis and coronary artery disease. (2022/12/12) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A novel TTR mutation (p.Ala65Val) underlying late-onset hereditary transthyretin (ATTRv) amyloidosis with mixed cardiac and neuropathic phenotype: a case report. (2022/12/09) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A case report of transcatheter repair of severe functional mitral regurgitation in cardiac amyloidosis. (2022/12/09) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Acute Decompensated Heart Failure Due to Combined Ischemic Cardiomyopathy and Cardiac Amyloidosis. (2022/12/07) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.